Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 041080/0138 | |
| Pages: | 6 |
| | Recorded: | 01/25/2017 | | |
| Attorney Dkt #: | 200096-US-CNT |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
09/24/2019
|
Application #:
|
15183088
|
Filing Dt:
|
06/15/2016
|
|
Publication #:
|
|
Pub Dt:
|
05/04/2017
| | | | |
|
Title:
|
PHARMACEUTICAL FORMULATION OF N-[5-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-2H-PYRAZOL-3-YL]-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE
|
|
|
Assignee
|
|
|
|
|
| 2 KINGDOM STREET |
| LONDON, ENGLAND W2 6BD |
|
|
Correspondence name and address
|
| |
ASTRAZENECA INTELLECTUAL PROPERTY
|
| |
950 WIND RIVER LANE
|
| |
GAITHERSBURG, MD 20878
|
Search Results as of:
09/24/2024 02:13 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
